Guardion Health Sciences, Inc.
GHSI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $12 | $11 | $7 | $2 |
| % Growth | 10.8% | 52.8% | 282.7% | – |
| Cost of Goods Sold | $7 | $7 | $4 | $2 |
| Gross Profit | $5 | $5 | $3 | -$0 |
| % Margin | 44% | 40.9% | 43% | -3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7 | $10 | $11 | $7 |
| SG&A Expenses | $9 | $12 | $14 | $8 |
| Sales & Mktg Exp. | $2 | $2 | $2 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $12 | $14 | $8 |
| Operating Income | -$4 | $0 | -$10 | -$9 |
| % Margin | -35.4% | 3.9% | -144.9% | -452.5% |
| Other Income/Exp. Net | $4 | $2 | $0 | -$0 |
| Pre-Tax Income | $0 | -$15 | -$25 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$30 | -$25 | -$9 |
| % Margin | 1.3% | -274% | -342.1% | -453.9% |
| EPS | 0.12 | -27.01 | -52.23 | -180.53 |
| % Growth | 100.4% | 48.3% | 71.1% | – |
| EPS Diluted | 0.12 | -27.01 | -52.23 | -180.53 |
| Weighted Avg Shares Out | 1 | 1 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $0 |
| EBITDA | -$4 | -$6 | -$10 | -$8 |
| % Margin | -32% | -55% | -134.1% | -441.6% |